AU2013207641A1 - Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses - Google Patents

Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses

Info

Publication number: AU2013207641A1
Authority: AU; Australia
Prior art keywords: human; viruses; cells; monoclonal antibodies; activity against
Prior art date: 2010-03-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2013207641A

Other versions

AU2013207641B2 (en

Inventor

Lee Hyun Joo

Kim Jong Mook

Yi Kye Sook

Chang Shin Jae

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Celltrion Inc

Original Assignee

Celltrion Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-03-08

Filing date

2013-07-19

Publication date

2013-08-08

2011-03-07 Priority claimed from AU2011225044A external-priority patent/AU2011225044B2/en

2013-07-19 Application filed by Celltrion Inc filed Critical Celltrion Inc

2013-07-19 Priority to AU2013207641A priority Critical patent/AU2013207641B2/en

2013-08-08 Publication of AU2013207641A1 publication Critical patent/AU2013207641A1/en

2016-01-14 Application granted granted Critical

2016-01-14 Publication of AU2013207641B2 publication Critical patent/AU2013207641B2/en

Status Ceased legal-status Critical Current

2031-03-07 Anticipated expiration legal-status Critical

Links

AU2013207641A 2010-03-08 2013-07-19 Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses Ceased AU2013207641B2 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
AU2013207641A AU2013207641B2 (en)	2010-03-08	2013-07-19	Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
KR20100020587		2010-03-08
KR10-2010-0020587		2010-03-08
AU2011225044A AU2011225044B2 (en)	2010-03-08	2011-03-07	Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses
AU2013207641A AU2013207641B2 (en)	2010-03-08	2013-07-19	Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2011225044A Division AU2011225044B2 (en)	2010-03-08	2011-03-07	Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses

Publications (2)

Publication Number	Publication Date
AU2013207641A1 true AU2013207641A1 (en)	2013-08-08
AU2013207641B2 AU2013207641B2 (en)	2016-01-14

Family

ID=44563977

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU2011225044A Ceased AU2011225044B2 (en)	2010-03-08	2011-03-07	Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses
AU2013207641A Ceased AU2013207641B2 (en)	2010-03-08	2013-07-19	Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU2011225044A Ceased AU2011225044B2 (en)	2010-03-08	2011-03-07	Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses

Country Status (11)

Country	Link
US (1)	US9573991B2 (en)
EP (3)	EP2860190A3 (en)
JP (1)	JP5795340B2 (en)
KR (1)	KR101297784B1 (en)
CN (1)	CN102791734B (en)
AU (2)	AU2011225044B2 (en)
CA (2)	CA2849668A1 (en)
EA (2)	EA201400855A1 (en)
IL (1)	IL221760A (en)
MX (1)	MX338758B (en)
WO (1)	WO2011111966A2 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2413962A1 (en)	2009-03-30	2012-02-08	Mount Sinai School of Medicine	Influenza virus vaccines and uses thereof
CN102939096B (en)	2010-02-18	2016-03-02	西奈山医学院	Vaccines for the prevention and treatment of influenza virus disease
US9708373B2 (en)	2010-03-30	2017-07-18	Icahn School Of Medicine At Mount Sinai	Influenza virus vaccine and uses thereof
ES2953393T3 (en) *	2011-09-20	2023-11-10	Icahn School Med Mount Sinai	Influenza virus vaccines and their uses
ES2641257T3 (en)	2011-09-30	2017-11-08	Celltrion, Inc.	Binding molecule that has neutralizing activity against influenza A virus produced from human B cells
KR20130059721A (en) *	2011-11-29	2013-06-07	(주)셀트리온	Human monoclonal antibody generated from human b-cells able to neutralize influenza a viruses
CA2892992A1 (en)	2011-12-02	2013-06-06	Aimm Therapeutics B.V.	Influenza a virus specific antibodies
KR101749316B1 (en) *	2011-12-15	2017-06-21	(주) 에이프로젠	A Highly Potent Broad-Spectrum Neutralizing Monoclonal Antibody Derived From H1N1-Infected Patients and Method Of Treatment of Virus By Using Thereof
US9969794B2 (en)	2012-05-10	2018-05-15	Visterra, Inc.	HA binding agents
US9834594B2 (en) *	2012-09-07	2017-12-05	Celltrion, Inc.	Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses
AR093446A1 (en)	2012-11-13	2015-06-10	Genentech Inc	ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE
CN108641002A (en)	2012-12-18	2018-10-12	西奈山伊坎医学院	Influenza virus vaccine and application thereof
WO2014159960A1 (en)	2013-03-14	2014-10-02	Icahn School Of Medicine At Mount Sinai	Antibodies against influenza virus hemagglutinin and uses thereof
KR20140118682A (en) *	2013-03-29	2014-10-08	(주)셀트리온	Composition comprising two or more influenza A viruses neutralizing binding molecules
US20160200799A1 (en) *	2013-08-23	2016-07-14	Fujita Health University	Anti-influenza virus neutralizing antibody
CN112877472A (en) *	2013-11-07	2021-06-01	小利兰·斯坦福大学理事会	Cell-free nucleic acids for analysis of human microbiome and components thereof
EP3076993A1 (en) *	2013-12-05	2016-10-12	Janssen Vaccines & Prevention B.V.	Process for preparing influenza vaccines
JPWO2016010160A1 (en) *	2014-07-18	2017-06-01	国立感染症研究所長	Anti-influenza virus antibody and use thereof
US20180008702A1 (en) *	2014-12-05	2018-01-11	Celltrion Inc.	Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing same
WO2016089181A1 (en) *	2014-12-05	2016-06-09	(주)셀트리온	Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing same
TWI702229B (en)	2014-12-19	2020-08-21	美商再生元醫藥公司	Human antibodies to influenza hemagglutinin
EP3247389A4 (en)	2015-01-23	2019-10-30	Icahn School of Medicine at Mount Sinai	VACCINATION REGIMES FOR INFLUENZA VIRUSES
US9890206B2 (en) *	2015-08-20	2018-02-13	Medigen Biotechnology Corporation	H1N1 flu virus neutralizing antibodies
WO2017083627A1 (en)	2015-11-13	2017-05-18	Visterra, Inc.	Compositions and methods for treating and preventing influenza
CN109195629A (en)	2016-02-24	2019-01-11	威特拉公司	Influenza antibody molecular preparation
JP7237344B2 (en)	2016-06-15	2023-03-13	アイカーンスクールオブメディシンアットマウントサイナイ	Influenza virus hemagglutinin protein and uses thereof
US12065482B2 (en) *	2016-08-10	2024-08-20	Celltrion Inc.	Stable liquid pharmaceutical formulation of anti-influenza virus antibody
US20180169780A1 (en) *	2016-12-19	2018-06-21	Anvil International, Llc	Cleanline threader
US11254733B2 (en)	2017-04-07	2022-02-22	Icahn School Of Medicine At Mount Sinai	Anti-influenza B virus neuraminidase antibodies and uses thereof
JP7403733B2 (en)	2017-09-04	2023-12-25	国立感染症研究所長	Method for manufacturing influenza HA split vaccine
BR112020014849A2 (en)	2018-01-26	2020-12-08	Regeneron Pharmaceuticals, Inc.	RECOMBINANT ISOLATED ANTIBODY OR ITS ANTIGEN BINDING FRAGMENT, PHARMACEUTICAL COMPOSITION, ISOLATED POLYNUCLEOTID MOLECULE, VECTOR, CELL, AND METHOD OF PREVENTING, TREATING OR IMPROVING THE LESS SYNTHESIS
TWI688653B (en) *	2018-01-30	2020-03-21	長庚醫療財團法人林口長庚紀念醫院	Preparation method, product and application of human anti-enterovirus type 71 monoclonal antibody
EP3810634A4 (en)	2018-06-21	2022-07-27	Icahn School of Medicine at Mount Sinai	INFLUENZA MOSAIC VIRUS HEMAGGLUTININ POLYPEPTIDES AND THEIR USES
BR112021001188A8 (en)	2018-07-23	2022-12-06	Japan As Represented By The Director General Of Nat Institute Of Infectious Diseases	COMPOSITION CONTAINING INFLUENZA VACCINE
KR20200060969A (en)	2018-11-23	2020-06-02	(주)셀트리온	Dosage Regimen For Treating Influenza Virus-Related Disease
BR112021017310A8 (en)	2019-03-04	2022-12-06	Japan As Represented By The Director General Of Nat Institute Of Infectious Diseases	METHOD TO PRODUCE INFLUENZA HA FRACTIONED VACCINE
JP2022521819A (en)	2019-03-25	2022-04-12	ビステラ，インコーポレイテッド	Compositions and Methods for Treating and Preventing Influenza
EP4212548A4 (en)	2020-09-08	2024-04-17	Novelgen Co., Ltd.	ANTIVIRAL COMPOSITION AGAINST THE INFLUENZA A VIRUS
CN120965865B (en) *	2025-10-15	2026-01-16	内蒙古盛健生物科技有限责任公司	Antibody for specifically treating aphtha of milk goat lamb and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2009524434A (en) *	2006-01-26	2009-07-02	エイチエックス・ダイアグノスティックス・インコーポレイテッド	Monoclonal antibodies that bind to avian influenza virus subtype H5 hemagglutinin and uses thereof
HRP20130163T1 (en) *	2006-09-07	2013-03-31	Crucell Holland B.V.	Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
CN101541832B (en) *	2006-09-07	2014-11-12	克鲁塞尔荷兰公司	Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
JP6149213B2 (en) *	2007-12-06	2017-06-21	デイナファーバーキャンサーインスティチュート，インコーポレイテッド	Antibodies against influenza viruses and methods of use thereof
US20100040635A1 (en)	2008-03-28	2010-02-18	Sea Lane Biotechnologies	Neutralizing antibodies to influenza viruses
US9340603B2 (en) *	2008-07-25	2016-05-17	Institute For Research In Biomedicine	Neutralizing anti-influenza A virus antibodies and uses thereof

2011
- 2011-03-07 JP JP2012556968A patent/JP5795340B2/en active Active
- 2011-03-07 KR KR1020110020061A patent/KR101297784B1/en active Active
- 2011-03-07 CA CA2849668A patent/CA2849668A1/en not_active Abandoned
- 2011-03-07 US US13/583,529 patent/US9573991B2/en active Active
- 2011-03-07 EA EA201400855A patent/EA201400855A1/en unknown
- 2011-03-07 CN CN201180013223.6A patent/CN102791734B/en active Active
- 2011-03-07 MX MX2012010406A patent/MX338758B/en active IP Right Grant
- 2011-03-07 WO PCT/KR2011/001563 patent/WO2011111966A2/en not_active Ceased
- 2011-03-07 EP EP14181741.1A patent/EP2860190A3/en not_active Withdrawn
- 2011-03-07 EP EP11753571.6A patent/EP2545074A4/en not_active Withdrawn
- 2011-03-07 CA CA2790949A patent/CA2790949C/en active Active
- 2011-03-07 AU AU2011225044A patent/AU2011225044B2/en not_active Ceased
- 2011-03-07 EP EP16175875.0A patent/EP3098236A1/en active Pending
- 2011-03-07 EA EA201201116A patent/EA021977B1/en not_active IP Right Cessation
2012
- 2012-09-03 IL IL221760A patent/IL221760A/en active IP Right Grant
2013
- 2013-07-19 AU AU2013207641A patent/AU2013207641B2/en not_active Ceased

Publication	Publication Date	Title
AU2013207641A1 (en)	2013-08-08	Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses
IL221760A (en)	2016-07-31	Human monoclonal antibodies derived from human b cells with neutralizing anti-influenza viruses
AU2016202543A1 (en)	2016-05-12	Human immunodeficiency virus (hiv)-neutralizing antibodies
ZA201403264B (en)	2017-08-30	Neutralizing gp41 antibodies and their use
EP2774076B8 (en)	2018-08-29	Fuzzy whitelisting anti-malware systems and methods
PL2710033T3 (en)	2021-10-25	HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING ANTIBODIES AND THEIR APPLICATION
LT2734545T (en)	2019-05-10	Neutralizing anti-influenza a virus antibodies and uses thereof
EP2663334A2 (en)	2013-11-20	Antibodies directed against influenza
ZA201701051B (en)	2018-05-30	Neutralizing anti-ccl20 antibodies
EP2788376A4 (en)	2015-09-09	NEUTRALIZING ANTIBODIES DIRECTED AGAINST HIV-1 AND THEIR USE
EP2629975A4 (en)	2017-10-25	Devices, systems, and methods for the fabrication of tissue
EP2657545A4 (en)	2018-01-03	Two-piece clip
SG10201506492PA (en)	2015-10-29	Improved antibodies of the class igg4
EP2552197A4 (en)	2013-09-25	Use of copolymer for increasing activity of pesticide
IL245924A0 (en)	2016-07-31	Topk peptides and vaccines including the same
AU2013253581A8 (en)	2016-03-31	Anti-human CD69 antibody, and use thereof for medical purposes
EP2596434A4 (en)	2017-12-13	Application activity system
SG11201403773WA (en)	2014-07-30	Monoclonal antibodies targeting neutralizing epitopes on h5 influenza virus of clade 2.3
EP2567239A4 (en)	2014-03-12	MASS SPECTROMETRY ASSAY FOR elF4E AND elF4E REGULON ACTIVITY
IL231065A0 (en)	2014-03-31	Microorganisms carrying a tumor antigen, compositons comprising same and uses thereof
EP2678925A4 (en)	2017-11-22	Devices, systems, and methods for energy conversion
EP2633450A4 (en)	2017-10-11	Systems and methods for scheduling changes
ZA201302156B (en)	2014-06-25	Method for protecting crops using insect-pathogenic viruses and cellulose sulfate
HK1178550A (en)	2013-09-13	Human group p immunodeficiency virus and uses thereof
HK1183898A (en)	2014-01-10	Influenza virus neutralizing agents that mimic the binding site of an influenza neutralizing antibody